We are live on
!
Find out more
IG
Ithaka Group Portfolio holdings
AUM
$482M
1-Year Est. Return
15.81%
This Fund
S&P 500
This Quarter
Est. Return
+10.78%
1 Year Est. Return
+15.81%
3 Year Est. Return
+99.18%
5 Year Est. Return
+112.16%
10 Year Est. Return
+745.06%
AUM
$595M
AUM Growth
+$37.6M
(+6.7%)
Cap. Flow
-$7.31M
Cap. Flow
% of AUM
-1.23%
Top 10 Holdings %
Top 10 Hldgs %
55.65%
Holding
42
New
2
Increased
4
Reduced
26
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$27.5M |
| 2 |
XYZ
Block Inc
XYZ
|
+$10.2M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$5.12M |
| 4 |
ServiceNow
NOW
|
+$3.99M |
| 5 |
TransUnion
TRU
|
+$1.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$14.8M |
| 2 |
Edwards Lifesciences
EW
|
+$14.2M |
| 3 |
Palo Alto Networks
PANW
|
+$14.1M |
| 4 |
Meta Platforms (Facebook)
META
|
+$11.6M |
| 5 |
Booking.com
BKNG
|
+$5.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.92% |
| 2 | Financials | 21.68% |
| 3 | Consumer Discretionary | 19.51% |
| 4 | Healthcare | 12.38% |
| 5 | Communication Services | 10.81% |
Similar funds
SDWIA
BAG
EFA
MAM
NQWM
BAM
BWA
HC
Ithaka Group's Q1 2018 Portfolio in Review
As of Q1 2018, Ithaka Group held 42 positions worth $595M, up 6.7% from $558M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Ithaka Group's Q1 2018 filing shows 2 new, 4 increased, 26 reduced and 3 closed positions. Its largest new stake was Block Inc: 223,024 shares worth $11M. The largest sale was Regeneron Pharmaceuticals, an estimated $14.8M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.
- Ithaka Group's largest Q1 2018 buy was Block Inc: 223,024 shares worth $11M.
- Ithaka Group added most to Microsoft in Q1 2018, an estimated $27.5M increase.
- Ithaka Group's biggest Q1 2018 reduction was Palo Alto Networks, cutting an estimated $14.1M.
- Ithaka Group fully exited Regeneron Pharmaceuticals in Q1 2018, selling an estimated $14.8M.
- Ithaka Group's ten largest holdings make up 56% of its $595M portfolio in Q1 2018.
- Ithaka Group opened 2 new positions and closed 3 in Q1 2018.
- Ithaka Group's portfolio value rose 6.7% quarter-over-quarter to $595M.
Based on Ithaka Group's 13F filing for Q1 2018, filed 14 May 2018.